Lymphoma
4 drugs527 FAERS reportsMedDRA PT
GET
/api/v1/reaction/lymphomaReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
Drugs reporting Lymphoma (4)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Becaplermin1100%
- 2Tafasitamab15818%
- 3Polatuzumab Vedotin3614.0%
- 4Sutimlimab72.6%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Diffuse Large B-cell Lymphoma2 shared · 0.20
- Blood Lactate Dehydrogenase Increased2 shared · 0.14
- Cytokine Release Syndrome2 shared · 0.05
- White Blood Cell Count Decreased2 shared · 0.02
- Covid-193 shared · 0.02
- Infection2 shared · 0.02
- Sepsis3 shared · 0.01
- Malignant Neoplasm Progression2 shared · 0.01
- Neutropenia2 shared · 0.01
- Thrombocytopenia2 shared · 0.01
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.